About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers

NCT00001055•National Institute of Allergy and Infectious Diseases (NIAID)

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

HIV Infections

Interventions

ALVAC-HIV MN120TMG (vCP205)

ALVAC-RG Rabies Glycoprotein (vCP65)

+1 more

Locations

6

United States

Locations (6)

UAB AVEG

Birmingham, Alabama, United States

JHU AVEG

Baltimore, Maryland, United States

St. Louis Univ. School of Medicine AVEG

St Louis, Missouri, United States

Univ. of Rochester AVEG

Rochester, New York, United States

Vanderbilt Univ. Hosp. AVEG

Nashville, Tennessee, United States

UW - Seattle AVEG

Seattle, Washington, United States

Key Dates

Completion Date

November 1, 1997

Last Updated

November 4, 2021

Related Studies

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047

HIVHIV Infections

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

NCT07428330

Cervix CancerHIV Infections+1 more

WiseApp for Spanish Speakers Living With HIV

NCT05398185

HIV InfectionsAcquired Immune Deficiency Syndrome+1 more

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

NCT07225530

HIV InfectionsHPV Infection+1 more

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

NCT07429864

HBVHBV Coinfection+7 more

View all related studies

Sponsors

Lead Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 4, 2021Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions